로딩 중…
지수 로딩 중…
코오롱생명과학
102940· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩47,850-2.35%
2026-06-19
Price Chart
코오롱생명과학+47.00%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 626.39B KRW |
| Revenue | 213.81B KRW |
| Net Income | -9.58B KRW |
| Total Assets | 1.15T KRW |
| Net Assets | 784.13B KRW |
| Employees | 444 |
| Value | |
| P/B | 0.80x |
| P/S | 2.93x |
| EV/EBITDA | 4678.84x |
| FCF Yield | -4.48% |
| Profitability | |
| ROE | -1.22% |
| ROA | -0.83% |
| Op. Margin | 0.08% |
| Revenue Growth | 10.76% |
| Earnings Growth | 98.91% |
| Financial Health | |
| Debt Ratio | 146.46% |
| Total Debt | 218.73B KRW |
| FCF | -28.05B KRW |
| Cash | 9.61B KRW |
| Current Ratio | 0.73x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 47.00% |
| 1M Return | -6.73% |
| From 52W High | -34.18% |
| 1Y MDD | -36.86% |
| Trading | |
| Volume | 18,488 shares |
| Foreign Own. | 5.03% |
| Per Share | |
| EPS | 2,799 KRW |
| BPS | 59,900 KRW |
Company Info
CEO 김선진
Employees 444
Founded 2000
HQ 서울특별시 강서구, KR
Kolon Life Science, established in 2000 and listed on KOSDAQ in 2009, focuses on the production of active pharmaceutical ingredients (APIs), antimicrobial agents, and bio-new drug research and development. Its pharmaceutical business supplies APIs and pharmaceutical intermediates globally, and it markets the eco-friendly antimicrobial brand Cleanbio for use in anti-dandruff shampoos and paints. The company is dedicated to cell and gene new drug development, concentrating on research and development for neuropathic pain treatments and anticancer drugs. Kolon Life Science is headquartered in Gangseo-gu, Seoul Metropolitan City.